Materias dentro de su búsqueda.
Mostrando 301 - 320 Resultados de 6,403 Para Buscar '"European Union"', tiempo de consulta: 0.27s Limitar resultados
  1. 301
    Publicado 2023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSE) in 2022
  2. 302
    “…This study aims to provide novel, up-to-date evidence on the economic burden across the 27 European Union (EU) countries in 2021. METHODS: Aggregate country-specific resource use data on morbidity, mortality, and health, social and informal care were obtained from international sources, such as the Statistical Office of the European Communities, enhanced by data from the European Society of Cardiology Atlas programme and patient-level data from the Survey of Health, Ageing and Retirement in Europe. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Economic burden of cardiovascular diseases in the European Union: a population-based cost study
  3. 303
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Level of positive mental health in the European Union: Results from the Eurobarometer 2002 survey
  4. 304
    “…The article first reviews the findings of MARQuIS and their implications for healthcare providers (and particularly for hospitals), and then addresses the broader policy implications for member states of the European Union (EU) and for the commission itself. Against the background of the European Commission’s Seventh Framework Programme, it then outlines a number of future areas for research to inform policy and practice in quality and safety in Europe. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Learning from MARQuIS: future direction of quality and safety in hospital care in the European Union
  5. 305
    por Cultrera, Concetta
    Publicado 2009
    “…INTRODUCTION: The announcement of the Commission strategy for supporting the quality of social services of general interest (SSGI) across the European Union in the Communication on “services of general interest, including social services of general interest: a new European commitment”. …”
    Enlace del recurso
    Texto
    The Commission strategy for supporting the quality of social services of general interest across the European Union
  6. 306
    Enlace del recurso
    Enlace del recurso
    Texto
    Evaluation of population newborn screening practices for rare disorders in member states of the European Union
  7. 307
    “…Here, we interrogate this thesis using the example of the European Union's regulation of emerging health technologies (such as nanotechnology). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    REGULATORY OR REGULATING PUBLICS? THE EUROPEAN UNION'S REGULATION OF EMERGING HEALTH TECHNOLOGIES AND CITIZEN PARTICIPATION
  8. 308
    “…The objective of this study was to analyze the risk posed by live animal imports for the introduction, in the European Union (EU), of four arboviruses that affect human and horses: Eastern and Western equine encephalomyelitis, Venezuelan equine encephalitis and Japanese encephalitis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identification of Hotspots in the European Union for the Introduction of Four Zoonotic Arboviroses by Live Animal Trade
  9. 309
    “…We present a systematic literature review assessing the potential for RVFV introduction and establishment in the United States (US) and European Union (EU). Viable pathways for the introduction of RVFV include: transport of virus-carrying vectors, importation of viremic hosts and intentional entry of RVFV as a biological weapon. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The risk of Rift Valley fever virus introduction and establishment in the United States and European Union
  10. 310
    “…BACKGROUND: The recent occurrence and spread of African swine fever (ASF) in Eastern Europe is perceived as a serious risk for the pig industry in the European Union (EU). In order to estimate the potential risk of ASF virus (ASFV) entering the EU, several pathways of introduction were previously assessed separately. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modular framework to assess the risk of African swine fever virus entry into the European Union
  11. 311
    “…Background Literature on health and access to care of undocumented migrants in the European Union (EU) is limited and heterogeneous in focus and quality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health and access to care for undocumented migrants living in the European Union: a scoping review
  12. 312
    “…BACKGROUND: The European Union has made it a strategic objective to develop its biofuels market in order to minimize greenhouse gas (GHG) emissions, to help mitigate climate change and to address energy insecurity within the transport sector. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bioethanol from poplar: a commercially viable alternative to fossil fuel in the European Union
  13. 313
    “…Objectives: The aim of this study was to review and compare current health technology assessment (HTA) activities for medical devices across non-European Union HTA agencies. Methods: HTA activities for medical devices were evaluated from three perspectives: organizational structure, processes, and methods. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES
  14. 314
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union
  15. 315
    por Ramirez, Isabelle
    Publicado 2015
    “…Objective: The purpose of this article is to give an overview of the complexities and unexpected regulatory requirements for obtaining approval of multinational and multicentre non-interventional studies (NIS) in the European Union (EU). Methods: The websites of national competent authorities (CAs), ethics committees (ECs) and data protection (DP) authorities were consulted to find regulations and guidance information related to the authorisation of NIS in various member states of the EU. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union
  16. 316
    “…To address the illicit cigarette trade, the European Union (EU) has signed agreements with the four major Transnational Tobacco Companies (TTCs) that involve establishing extensive systems of cooperation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of the European Union's illicit trade agreements with the four major Transnational Tobacco Companies
  17. 317
    “…OBJECTIVE: This study compares the performances of new-molecule (NM) launches in Turkey with those in the European Union and United States for the years 2007–2013. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Delay and restricted access of new molecules in Turkey compared to the United States and European Union
  18. 318
    “…Objectives: The aim of this study is to identify and describe the barriers to market access of biosimilar mAbs in the European Union and to analyze how these barriers could be overcome. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
  19. 319
    “…In this research, population growth of the European Union (EU) until the year 2080 and the number of patients with AD are modeled. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prediction of population with Alzheimer’s disease in the European Union using a system dynamics model
  20. 320
    “…Two countries achieved ≥90% for all stages, and more than half had reached ≥90% for at least 1 stage. CONCLUSIONS. European Union countries are nearing the 90-90-90 target. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges
Herramientas de búsqueda: RSS